Form D · Biotechnology
TARGEGEN INC
San Diego, CA · CIK 0001170149
Offering snapshot reported Sep 21, 2009 · SEC filing
- Reported sold
- $3.73M Offering amount: $8.54M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 9, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 21, 2009 | Initial | $3,728,379 | No comparison | 18 | SEC filing |
| Jul 30, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 26, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 1, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-41385
Source: Form D, filed Sep 21, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Annette Bianchi | Director |
| Peter H. Bissinger | Director |
| Juerg Eckhardt | Director |
| Wood C. Erwin | Executive |
| Forrest H. Fuller | Executive |
| David E. Mc Clure | Executive |
| Arda M. Minocherhomjee | Director |
| Ivor Royston | Director |
| Phillip Schneider | Director |
| Andrew E. Senyei | Director |
| Jolene Shorr | Executive |
| Peter G. Ulrich | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9380 Judicial Drive
San Diego, CA, 92121
San Diego, CA, 92121